Charles River Laboratories (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRL | RVTY | HQY | ||
| Company | Charles River Laboratories | Revvity Inc | Healthequity | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NASDAQ | ||
| Open | 229.50 | 113.37 | 92.66 | ||
| High | 231.46 | 114.51 | 95.53 | ||
| Low | 226.95 | 112.19 | 91.88 | ||
| Latest | 230.69 | 113.76 | 95.31 | ||
| Change | +1.60 | +0.92 | +3.02 | ||
| % Change | +0.70% | +0.82% | +3.27% | ||
| Volume | 845,300 | 972,300 | 986,200 | ||
| 20-Day Average Volume | 873,505 | 1,506,540 | 1,032,715 | ||
| Previous Close | 229.09 | 112.84 | 92.29 | ||
| Industry | Medical Services | Medical Services | Medical Services | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 197.84 | 104.37 | 87.76 | ||
| 20-Day Raw Stochastic | 89.73% | 87.57% | 98.23% | ||
| 20-Day Relative Strength | 73.40 | 65.31 | 64.13 | ||
| Weighted Alpha | +55.56 | +21.70 | +0.52 | ||
| Today's Opinion | 56% Buy | 88% Buy | 40% Buy | ||
| Previous Opinion | 56% Buy | 72% Buy | 40% Buy | ||
| Last Month's Opinion | 48% Sell | 56% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.45% since 06/25/26 | +0.20% since 06/25/26 | +14.24% since 06/25/26 | ||
| Low | 210.00 on 06/26/26 | 109.62 on 06/30/26 | 83.73 on 06/26/26 | ||
| High | 236.62 on 07/01/26 | 116.16 on 06/26/26 | 95.53 on 07/02/26 | ||
| 1-Month | |||||
| %Chg | +31.98% since 06/02/26 | +13.32% since 06/02/26 | +7.89% since 06/02/26 | ||
| Low | 169.46 on 06/03/26 | 96.86 on 06/17/26 | 83.10 on 06/25/26 | ||
| High | 236.62 on 07/01/26 | 116.16 on 06/26/26 | 95.53 on 07/02/26 | ||
| 3-Month | |||||
| %Chg | +32.66% since 04/02/26 | +27.91% since 04/02/26 | +12.57% since 04/02/26 | ||
| Low | 146.20 on 05/19/26 | 81.22 on 04/29/26 | 76.03 on 04/13/26 | ||
| High | 236.62 on 07/01/26 | 116.16 on 06/26/26 | 95.53 on 07/02/26 | ||
| 6-Month | |||||
| %Chg | +13.97% since 01/02/26 | +15.90% since 01/02/26 | +4.66% since 01/02/26 | ||
| Low | 146.20 on 05/19/26 | 81.22 on 04/29/26 | 72.76 on 02/17/26 | ||
| High | 236.62 on 07/01/26 | 118.30 on 01/22/26 | 99.50 on 01/08/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 11,111,874 | 12,691,065 | 7,968,106 | ||
| Shares Outstanding, K | 48,168 | 111,560 | 83,602 | ||
| Annual Sales | 4,015,380,000 | 2,856,050,000 | 1,313,430,000 | ||
| Annual Net Income | -144,340,000 | 241,200,000 | 215,200,000 | ||
| Last Quarter Sales | 995,830,000 | 711,120,000 | 354,640,000 | ||
| Last Quarter Net Income | -14,840,000 | 40,720,000 | 69,420,000 | ||
| 60-Month Beta | 1.40 | 1.09 | 0.21 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.06 on 05/07/26 | 1.06 on 05/05/26 | 1.24 on 05/28/26 | ||
| Earnings Date | 08/05/26 | 07/27/26 | 09/01/26 | ||
| Most Recent Dividend | N/A | 0.070 on 04/17/26 | N/A | ||
| Next Ex-Dividends Date | N/A | 07/17/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 22.91 | 22.04 | 25.71 | ||